These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 10918072)

  • 41. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.
    Pérez-Tomás R
    Curr Med Chem; 2006; 13(16):1859-76. PubMed ID: 16842198
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multidrug-resistance P-glycoprotein (MDR1) secretes platelet-activating factor.
    Raggers RJ; Vogels I; van Meer G
    Biochem J; 2001 Aug; 357(Pt 3):859-65. PubMed ID: 11463358
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ATP-dependent transport of lipophilic cytotoxic drugs by membrane vesicles prepared from MRP-overexpressing HL60/ADR cells.
    Paul S; Breuninger LM; Kruh GD
    Biochemistry; 1996 Nov; 35(44):14003-11. PubMed ID: 8909298
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of 12 Ca2+ antagonists on multidrug resistance, MDR1-mediated transport and MDR1 mRNA expression.
    Takara K; Sakaeda T; Tanigawara Y; Nishiguchi K; Ohmoto N; Horinouchi M; Komada F; Ohnishi N; Yokoyama T; Okumura K
    Eur J Pharm Sci; 2002 Aug; 16(3):159-65. PubMed ID: 12128170
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytotoxic effects of 27 anticancer drugs in HeLa and MDR1-overexpressing derivative cell lines.
    Takara K; Sakaeda T; Yagami T; Kobayashi H; Ohmoto N; Horinouchi M; Nishiguchi K; Okumura K
    Biol Pharm Bull; 2002 Jun; 25(6):771-8. PubMed ID: 12081145
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel human multidrug resistance gene MDR1 variant G571A (G191R) modulates cancer drug resistance and efflux transport.
    Yang Z; Wu D; Bui T; Ho RJ
    J Pharmacol Exp Ther; 2008 Nov; 327(2):474-81. PubMed ID: 18723777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of P-glycoprotein in intestinal transport versus the BBB transport of tetraphenylphosphonium.
    Swed A; Eyal S; Madar I; Zohar-Kontante H; Weiss L; Hoffman A
    Mol Pharm; 2009; 6(6):1883-90. PubMed ID: 19722701
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative effect of verapamil, cyclosporin A and SDZ PSC 833 on rhodamine 123 transport and cell cycle in vinblastine-resistant Chinese hamster ovary cells overexpressing P-glycoprotein.
    Pétriz J; Sánchez J; Bertrán J; García-López J
    Anticancer Drugs; 1997 Oct; 8(9):869-75. PubMed ID: 9402314
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter. Modulation of substrate specificity by a point mutation.
    Ozvegy C; Váradi A; Sarkadi B
    J Biol Chem; 2002 Dec; 277(50):47980-90. PubMed ID: 12374800
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence for multidrug resistance-1 P-glycoprotein-dependent regulation of cellular ATP permeability.
    Roman RM; Lomri N; Braunstein G; Feranchak AP; Simeoni LA; Davison AK; Mechetner E; Schwiebert EM; Fitz JG
    J Membr Biol; 2001 Oct; 183(3):165-73. PubMed ID: 11696858
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents.
    Pascaud C; Garrigos M; Orlowski S
    Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):351-8. PubMed ID: 9657975
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1.
    Renes J; de Vries EG; Nienhuis EF; Jansen PL; Müller M
    Br J Pharmacol; 1999 Feb; 126(3):681-8. PubMed ID: 10188979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction of human P-glycoprotein in Caco-2 cells: development of a highly sensitive assay system for P-glycoprotein-mediated drug transport.
    Shirasaka Y; Kawasaki M; Sakane T; Omatsu H; Moriya Y; Nakamura T; Sakaeda T; Okumura K; Langguth P; Yamashita S
    Drug Metab Pharmacokinet; 2006 Oct; 21(5):414-23. PubMed ID: 17072095
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Xenopus laevis oocytes expressing human P-glycoprotein: probing trans- and cis-inhibitory effects on [3H]vinblastine and [3H]digoxin efflux.
    Jutabha P; Wempe MF; Anzai N; Otomo J; Kadota T; Endou H
    Pharmacol Res; 2010 Jan; 61(1):76-84. PubMed ID: 19631272
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines.
    van der Sandt IC; Blom-Roosemalen MC; de Boer AG; Breimer DD
    Eur J Pharm Sci; 2000 Sep; 11(3):207-14. PubMed ID: 11042226
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Global alteration of the drug-binding pocket of human P-glycoprotein (ABCB1) by substitution of fifteen conserved residues reveals a negative correlation between substrate size and transport efficiency.
    Vahedi S; Chufan EE; Ambudkar SV
    Biochem Pharmacol; 2017 Nov; 143():53-64. PubMed ID: 28728917
    [TBL] [Abstract][Full Text] [Related]  

  • 57. P-glycoprotein catalytic mechanism: studies of the ADP-vanadate inhibited state.
    Urbatsch IL; Tyndall GA; Tombline G; Senior AE
    J Biol Chem; 2003 Jun; 278(25):23171-9. PubMed ID: 12670938
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Restoring uptake and retention of daunorubicin and idarubicin in P170-related multidrug resistance cells by low concentration D-verapamil, cyclosporin-A and SDZ PSC 833.
    Michieli M; Damiani D; Michelutti A; Candoni A; Masolini P; Scaggiante B; Quadrifoglio F; Baccarani M
    Haematologica; 1994; 79(6):500-7. PubMed ID: 7896208
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of ABCB1 (MDR1) and ABCB4 (MDR3) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cells.
    Duan Z; Brakora KA; Seiden MV
    Mol Cancer Ther; 2004 Jul; 3(7):833-8. PubMed ID: 15252144
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug binding to P-glycoprotein is inhibited in normal tissues following SDZ-PSC 833 treatment.
    Jetté L; Murphy GF; Béliveau R
    Int J Cancer; 1998 May; 76(5):729-37. PubMed ID: 9610733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.